Cargando...
Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnostics
Since 2013 next-generation sequencing (NGS) targeting genes mutated in diffuse gliomas is part of routine diagnostics in our institute. In the present report, we evaluate the use of this custom tailored NGS platform on 434 samples. The NGS panel assesses mutations in ATRX, CIC, EGFR, FUBP1, NOTCH1,...
Gardado en:
| Publicado en: | Acta Neuropathol Commun |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6251173/ https://ncbi.nlm.nih.gov/pubmed/30470264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40478-018-0633-y |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|